Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06900400
Recruiting Not applicable

Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder

NCT06900400 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2024-11-11
Last updated
2025-03-28

Condition(s) studied

ADHD - Attention Deficit Disorder With Hyperactivity

Investigational drug(s) / intervention(s)

Sustained-Paced Finger Tapping" (Petilli et al., 2018)

Sustained-Paced Finger Tapping" (Petilli et al., 2018): Sustained-Paced Finger Tapping" (Petilli et al., 2018) a computerized test that lasts approximately 10 minutes. It involves maintaining and reproducing the rhythm of a sound (auditory version).

Study summary

Subjects with ADHD may exhibit deficits in sustained internal attention. The "Sustained-Paced Finger Tapping" test was recently developed and experimentally used in international literature to assess sustained internal attention in typically developing children. This clinical study has several objectives: 1) to assess the presence of "internal" sustained attention deficits in children with ADHD through the "Sustained-Paced Finger Tapping"; 2) to evaluate the discriminant and ecological validity of the "Sustained-Paced Finger Tapping."

Eligibility

Sex
ALL
Min age
6 Years
Max age
13 Years
Healthy volunteers
Accepted
Inclusion Criteria: * ADHD Group (1) Subjects with a diagnosis of ADHD of any severity level and subtype * ADHD Group (2) "Medication-naive" ADHD subjects, meaning subjects who have not been prescribed and/or have not yet started any pharmacological treatment for ADHD * ADHD Group (3) IQ ≥ 70 * Non-ADHD Group, Normal IQ Exclusion Criteria: * for both groups, symptomatology suggestive of autism spectrum disorders, psychotic disorders, mood disorders, and anxiety disorders * for both groups, use of psychotropic drugs * for both groups, subjects with cerebral palsy and/or neuromotor and neuromuscular disorders * for both groups, CNS diseases, e.g., epilepsy and/or neurodegenerative diseases, or central nervous system injuries resulting from, for example, head trauma or stroke * for the non-ADHD group, presence of ADHD symptoms

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Associazione "La Nostra Famiglia"-IRCCS "E. Medea"-Scientific Hospital for Neurorehabilitation-Unit for Severe Disabilities in Developmental Age and Young Adults (Developmental Neurology and Neurorehabilitation) Brindisi Italy Recruiting
Università del Salento Lecce Italy Recruiting

More IRCCS Eugenio Medea trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06900400 on ClinicalTrials.gov ↗ ← All trials in Italy